Arcus Biosciences, Inc. (RCUS) Operating cash flow 2016–2025
Arcus Biosciences, Inc. (RCUS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$482.0MFY2025 · since FY2016: -$12.9M → -$482.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$482.0M | -183.5% |
| FY2024 | -$170.0M | +44.4% |
| FY2023 | -$306.0M | -169.9% |
| FY2022 | $438.0M | +271.1% |
| FY2021 | -$256.0M | -330.6% |
| FY2020 | $111.0M | +251.1% |
| FY2019 | -$73.5M | -70.9% |
| FY2018 | -$43.0M | -71.6% |
| FY2017 | -$25.1M | -93.6% |
| FY2016 | -$12.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice